Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Seaport Therapeutics, Inc. - Common Stock
(NQ:
SPTX
)
18.99
-0.65 (-3.31%)
Streaming Delayed Price
Updated: 2:03 PM EDT, Sep 29, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
148,735
Open
19.46
Bid (Size)
19.06 (300)
Ask (Size)
19.55 (200)
Prev. Close
19.64
Today's Range
18.60 - 19.80
52wk Range
14.85 - 28.38
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Seaport Therapeutics to Participate in September Investor Conferences
September 14, 2026
From
Seaport Therapeutics, Inc.
Via
Business Wire
PureTech Founded Entity Seaport Therapeutics Reports Positive Topline Results from Phase 1 Driving Simulation Trial of GlyphAllo™ in Healthy Volunteers
September 09, 2026
From
PureTech Health plc
Via
Business Wire
Performance
YTD
-4.3%
-4.3%
1 Month
-19.8%
-19.8%
3 Month
-15.7%
-15.7%
6 Month
-4.3%
-4.3%
1 Year
-4.3%
-4.3%
More News
Read More
Seaport Therapeutics Reports Positive Topline Results from Phase 1 Driving Simulation Trial of GlyphAllo™ in Healthy Volunteers
September 09, 2026
From
Seaport Therapeutics, Inc.
Via
Business Wire
Seaport Therapeutics to Present at Citi’s 2026 Biopharma Back to School Conference and Participate in 21st Annual Wells Fargo Healthcare Conference
August 31, 2026
From
Seaport Therapeutics, Inc.
Via
Business Wire
Seaport Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
August 03, 2026
From
Seaport Therapeutics, Inc.
Via
Business Wire
PureTech Founded Entity Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo™ in Healthy Volunteers
June 09, 2026
From
PureTech Health plc
Via
Business Wire
Seaport Therapeutics Reports First Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
June 08, 2026
From
Seaport Therapeutics, Inc.
Via
Business Wire
Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo™ in Healthy Volunteers
June 08, 2026
From
Seaport Therapeutics, Inc.
Via
Business Wire
Seaport Therapeutics to Participate in Two Upcoming Investor Conferences
June 01, 2026
From
Seaport Therapeutics, Inc.
Via
Business Wire
Frequently Asked Questions
Is Seaport Therapeutics, Inc. - Common Stock publicly traded?
Yes, Seaport Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Seaport Therapeutics, Inc. - Common Stock trade on?
Seaport Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Seaport Therapeutics, Inc. - Common Stock?
The ticker symbol for Seaport Therapeutics, Inc. - Common Stock is SPTX on the Nasdaq Stock Market
What is the current price of Seaport Therapeutics, Inc. - Common Stock?
The current price of Seaport Therapeutics, Inc. - Common Stock is 18.99
When was Seaport Therapeutics, Inc. - Common Stock last traded?
The last trade of Seaport Therapeutics, Inc. - Common Stock was at 09/29/26 02:03 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
